Adherence to nucleos(t)ide analogues for chronic hepatitis B in clinical practice and correlation with virological breakthroughs. (Q51178953)

31 March 2018

title

Adherence to nucleos(t)ide analogues for chronic hepatitis B in clinical practice and correlation with virological breakthroughs. (English)

1 reference

31 March 2018

0 references

1 reference

W Chotiyaputta

1

1 reference

31 March 2018

C Hongthanakorn

2

1 reference

31 March 2018

K Oberhelman

3

1 reference

31 March 2018

R J Fontana

4

1 reference

31 March 2018

T Licari

5

1 reference

31 March 2018

A S F Lok

6

1 reference

31 March 2018

publication date

14 July 2011

1 reference

31 March 2018

Journal of Viral Hepatitis

published in

1 reference

31 March 2018

volume

19

1 reference

31 March 2018

issue

3

1 reference

31 March 2018

page(s)

205-212

1 reference

31 March 2018

A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01494.X

Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01494.X

Telbivudine versus lamivudine in patients with chronic hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01494.X

Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01494.X

Week 48 resistance surveillance in two phase 3 clinical studies of adefovir dipivoxil for chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01494.X

Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01494.X

Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01494.X

Impact of adherence to statins on coronary artery disease in primary prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01494.X

Impact of adherence to antihypertensive agents on clinical outcomes and hospitalization costs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01494.X

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01494.X

Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01494.X

Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01494.X

21 January 2018

Adherence to Medication

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01494.X

Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01494.X

Optimal recall period and response task for self-reported HIV medication adherence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01494.X

Sensitivity and accuracy of an updated line probe assay (HBV DR v.3) in detecting mutations associated with hepatitis B antiviral resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01494.X

A comparison study of multiple measures of adherence to HIV protease inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01494.X

Reasons for ART non-adherence in the Deep South: adherence needs of a sample of HIV-positive patients in Mississippi

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01494.X

Prescription drug coverage, health, and medication acquisition among seniors with one or more chronic conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01494.X

Impact of a prescription copayment increase on lipid-lowering medication adherence in veterans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01494.X

Long term persistence with statin treatment in daily medical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01494.X

Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01494.X

Not all missed doses are the same: sustained NNRTI treatment interruptions predict HIV rebound at low-to-moderate adherence levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01494.X

Predictors of virologic failure and resistance in HIV-infected patients treated with nevirapine- or efavirenz-based antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01494.X

Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01494.X

Long-term adherence to statin treatment in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01494.X

10.1111/J.1365-2893.2011.01494.X

21 January 2018

Identifiers

DOI

1 reference

31 March 2018

1 reference

31 March 2018